Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.

Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.

Item
http://www.wikidata.org/entity/Q33370041
Overview and recent advances in the treatment of neuroblastoma.Optimization of liposomal topotecan for use in treating neuroblastoma.Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directionsOutcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move ForwardA review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma.Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyCurrent concepts on the surgical and medical management of osteosarcoma.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO).Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma.Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.
P2860

Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.

Item
http://www.wikidata.org/entity/Q33370041
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@ast
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@en
type
label
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@ast
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@en
prefLabel
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@ast
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Topotecan by 21-day continuous ...... ildren's Oncology Group study.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698